Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Colorectal Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Colorectal Cancer
    Annual Report Finds Declines in Cancer Incidence and Death in US, But Wide Variation in Lung Cancer Trends - (DGNews)
    TopAbstracts in Colorectal Cancer 11/26/2008 - (DGNews)
    TopAbstracts in Colorectal Cancer 11/12/2008 - (DGNews)
    Imaging Surveillance of Small Polyps, an Alternative to Immediate Colonoscopy - (DGNews)
    TopAbstracts in Colorectal Cancer 10/29/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Colorectal Cancer
  • Treatment of Advanced Colorectal Cancer: What Are the Clinical Implications of Latest Data?
  • Update on Targeted Therapies in mCRC: How to Choose to Maximize Efficacy and Minimize Toxicity
  • Interpreting Current Evidence in mCRC: Progress Towards Individualized Therapy
  • Colorectal Cancer Screening and Prevention

    Webcasts/CME archive

     Recent cases - Colorectal Cancer
      Metastatic Colorectal Cancer to a Primary Thyroid Cancer
      Late Recurrence of Large Peri-Stomal Metastasis Following Abdomino-Perineal Resection of Rectal Cancer
      Cytomegalovirus Colitis in a Patient with Recurrent Colon Cancer After Systemic Chemotherapy: A Case Report
      Solitary Mediastinal Lymph Node Metastasis in Rectosigmoid Carcinoma: A Case Report
      Pulmonary Lymphangitic Carcinomatosis as a Primary Manifestation of Colon Cancer in a Young Adult

      Cases archive
        




      my personal edition > colorectal cancer > news
      divider

        E-Mail this DGNews to a colleague

      DGNews


      FDA Approves Eloxatin (Oxaliplatin) for Treatment of Advanced Colorectal Cancer

      LOS ANGELES, CA -- January 12, 2004 -- Sanofi-Synthelabo today announced that EloxatinŽ (oxaliplatin for injection) received approval from the U.S. Food and Drug Administration (FDA) for the first-line treatment of advanced colorectal cancer. The first-line Eloxatin-based regimen, Folfox, demonstrated improved survival and a lower incidence of common chemotherapy-related side effects compared with a standard treatment regimen, IFL.

      More news:
      - Eloxatin (as part of the FOLFOX4 regimen) also is being studied in combination with the experimental oral angiogenesis inhibitors Avastin (Genentech) and PTK/ZK (Novartis/Schering AG). Oral angiogenesis inhibitors are agents that effectively target the tumor blood vessels, slowing tumor growth and spread.

      - Extensive worldwide clinical development program is ongoing to explore the benefit of Eloxatin in other types of cancers, primarily pancreatic and gastric cancer.


      SOURCE: Sanofi-US.



      E-Mail this DGNews to a colleague   To print, use this version






      All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send